Thyroid Tumors in Mice: Insights from E7 and RET/PTC3 Models
Author Information
Author(s): Jin L, Burniat A, Dumont J-E, Miot F, Corvilain B, Franc B
Primary Institution: Institut de Recherche Interdisciplinaire (IRIBHM), Université Libre de Bruxelles
Hypothesis
The study investigates the differences in tumorigenesis between E7 and RET/PTC3 transgenic mouse models of thyroid cancer.
Conclusion
The E7 model shows a dominant goitrous pattern with no tumor formation, while the RET/PTC3 model develops tumors with significant heterogeneity.
Supporting Evidence
- The E7 model showed a predominant goitrous phenotype without tumor formation.
- 28% of RET/PTC3 mice developed tumors by 6 and 10 months.
- Distinct cellular changes were observed in both E7 and RET/PTC3 models.
- Proliferation indices were higher in E7 than in RET/PTC3 at all ages.
- Histological features in RET/PTC3 included cribriform patterns and solid tumors.
Takeaway
Scientists studied mice with different genes to see how they develop thyroid tumors, finding that one type of mouse had tumors while the other just had enlarged thyroids.
Methodology
The study involved immunohistological analysis of thyroids from E7 and RET/PTC3 transgenic mice, assessing cell proliferation and signaling pathways.
Limitations
The study's duration was limited to 10 months, which may not capture the full tumor development timeline.
Participant Demographics
Transgenic mice (E7, RET/PTC3, and wild-type C57Bl/6) aged 2 to 10 months.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website